Across TCGA pan-cancer cohorts, BCDIN3D Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated BCDIN3D data layer compared with 25 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher BCDIN3D Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated BCDIN3D expression acts as an unfavorable survival marker.

LUAD, GBM, and STAD are the cancer types where BCDIN3D Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.036	0.791	<.001	18	view →
GBM	DFS	Median	All	0.043	0.257	<.001	12	view →
STAD	OS	Median	II,III,IV	0.215	0.660	.019	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: BCDIN3D tumor-vs-normal RNA expression · all BCDIN3D data types